Insulin growth factor-1 and insulin growth factor binding protein-3 in Egyptian patients with chronic hepatitis C

Archives of Medical Science

Volumn 3, Issue 1, 2007, Pages 46-51

  Raslan, Hala Mohamed ^a   Ezzat, Wafaa Mohamed ^a   Ahmed, Mohamed Mahmoud ^a   Rasheed, Enas Abdel ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Chronic hepatitis; IGF 1; IGFBP 3; Liver cirrhosis

Indexed keywords

ALBUMIN; ASPARTATE AMINOTRANSFERASE; PROTHROMBIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; LABORATORY TEST; LIVER CIRRHOSIS; MALE; PROTEIN BLOOD LEVEL; SCHISTOSOMIASIS;

EID: 34247352862     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Garcia-Fernandez M, Castilla-Cortazar I, Diaz-Sanchez M, et al. Effect of IGF-1 on total serum antioxidant status in cirrhotic rats. J Physiol Biochem 2003; 59: 145-6.
2. Tritos NA, Mantzoros CS. Recombinant human growth hormone: old and novel uses. Am J Med 1998; 105: 44-57.
3. Zapf J, Kiefer M., Merryweather J. Isolation from adult human serum of four insulin-like growth factor (IGF) binding proteins and molecular cloning of one of them that is increased by IGF I administration and in extrapancreatic tumor hypoglycemia. J Biol Chem 1990; 265: 14892-8.
4. Wang XZ, Chen ZX, Zhang LJ, et al. Expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor and its intervention by interleukin-10 in experimental hepatic fibrosis. World J Gastroenterol 2003; 9: 1287-91.
5. Donaghy A, Ross R, Gimson A, Hughes S, Holly J, Wiliams R. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease. Hepatology 1995; 21: 680-8.
6. Moller S, Becker U, Juul A, Skakkebaek NE, Christensen E. Prognostic value of insulinlike growth factor 1 and its binding protein in patients with alcohol-induced liver disease. EMALD group. Hepatology 1996; 23: 1073-8.
7. Sidlova K, Pechova M, AKotaska K, Prusa R. Insulin-like growth factor binding protein-3 in patients with liver cirrhosis. Physiol Res 2002; 51: 587-90.
8. Teale JD. The diagnostic application of serum growth hormone, insulin-like growth factor (IGF), and IGF binding protein measurements. J Int Fed Clin Chem 1995; 6: 164-8.
9. Donaghy AJ, Delhanty PJ, Ho KK, Williams R, Baxter RC. Regulation of the growth hormone receptor/binding protein, insulin-like growth factor ternary complex system in human cirrhosis. J Hepatol 2002; 36: 751-8.
10. Baxter RC. Circulating binding proteins for the insulin-like growth factors. Trends Endocrinol Metab 1993; 4: 91-6.
11. Weber MM, Auernhammer CJ, Lee PD, Engelhardt D, Zachoval R. Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation. Horm Res 2002; 57: 105-12.
12. Scharf JG, Schmitz F, Frystyk J, et al. Insulin-like growth factor-1 serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease. J Hepatol 1996; 25: 689-99.
13. Wu YL, Ye J, Zhang S, Zhong J, Xi RP. Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis. World J Gastroenterol 2004; 10: 2740-3.
14. Vyzantiadis T, Theodoridou S, Giouleme O, Harsoulis P, Evgenidis N, Vyzantiadis A. Serum concentration of insulin-like growth factor-1 (IGF-1) in patients with liver cirrhosis. Hepatogastroenterology 2003; 50: 814-16.
15. Ottesen LH, Bendtsen F, Flyvbjerg A. The insulin-like growth factor binding protein 3 ternary complex is reduced in cirrhosis. Liver 2001; 21: 350-6.
16. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
17. Shaarawy M, Fikry MA, Massoud BA, Lotfy S. Insulin-like growth factor binding protein-3: a novel biomarker for the assessment of the synthetic capacity of hepatocytes in liver cirrhosis. J Clin Endocrinol Metab1998; 83 :3316-9.
18. Cuneo RC, Hickman PE, Wallace JD, et al. Altered endogenous growth hormone secretory kinetics and diurnal-GH binding protein profiles in adult with chronic liver disease. Clin Endocrinol 1995; 43: 265-75.
19. Assy N, Hochberg Z, Amit T, Shen-Orr Z, Enat R, Baruch Y. Growth hormone-stimulated insulin-like growth factor-1 (IGF) and IGF-binding protein-3 in liver cirrhosis. J Hepatol 1997; 27: 796-802.
20. Kaklamani VG, Linos A, Kaklamani E, Markaki I, Mantzoros C. Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3. J Clin Oncol 1999; 17: 813-7.
21. Goodman-Gruen D, Barrett-Connor E. Epidemiology of insulin-like growth factor-1 in elderly men and women: The Rancho Bernardo Study. Am J Epidemiol 1997; 145: 970-6.
22. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, et al. Serum insulin-like growth factor-1 in a random population sample of men and women: Relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol 1994; 41: 351-7.